Phathom Pharmaceuticals, Inc.

This study tests a daily pill called vonoprazan against a placebo in 80 adults with eosinophilic esophagitis, a condition where food allergies cause throat inflammation and trouble swallowing. The main goal is to see if the drug reduces allergic cells in the throat after 12 weeks…